coads,
I'd prefer an announcement from WP on likely time frames, but in fairness to him the previous time frames have been met and I see no reason why that will not be the case in the future.
I do recall an announcement that the path to commercialisation could be four years.
In the meantime apart from a bit of confidence building for shareholders through announcements, rather than speculation, in reality the share price suggests there's not a lot to complaint about.
Ann: Updated 30-day DurAVR THV Clinical Data, page-28
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.17 |
Change
-0.050(0.25%) |
Mkt cap ! $387.7M | |||
| Open | High | Low | Value | Volume |
| $20.20 | $20.50 | $20.00 | $71.28K | 3.532K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 776 | $20.17 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.18 | 1200 | 1 |
View Market Depth
| Last trade - 16.10pm 16/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$20.16 |
Change
-0.050 ( 0.69 %) |
||||
| Open | High | Low | Volume | ||
| $20.17 | $20.17 | $20.09 | 129 | ||
| Last updated 15.56pm 16/05/2024 ? | |||||
| AVR (ASX) Chart |